[KYMR] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[KYMR] Kymera Therapeutics, Inc.
Announcement Date
04-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -7.45%
YoY- -0.41%
Quarter Report
KYMR's Result
KYMR's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 47,885 4,728 16,513 9,466 16,139 9,551 11,514 157.94%
PBT -14,368 -52,867 -38,799 -40,928 -34,865 -43,002 -40,257 -49.58%
Tax 4,996 -895 4,632 -4,343 -818 1,916 -553 -
NP -14,368 -52,867 -38,799 -36,585 -34,047 -43,002 -39,704 -49.12%
Tax Rate - - - - - - - -
Total Cost 62,253 57,595 55,312 46,051 50,186 52,553 51,218 13.85%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -30.01 -1,118.17 -234.96 -386.49 -210.96 -450.24 -344.83 -80.27%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.25 -0.90 -0.67 -0.63 -0.59 -0.79 -0.77 -52.66%
EPS Diluted -0.25 -0.90 -0.67 -0.63 -0.59 -0.79 -0.77 -52.66%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.